NTRB
Nutriband Inc (NTRB)
Healthcare • NASDAQ • $3.14+2.95%
- Symbol
- NTRB
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $3.14
- Daily Change
- +2.95%
- Market Cap
- $35.25M
- Trailing P/E
- N/A
- Forward P/E
- -12.61
- 52W High
- $11.68
- 52W Low
- $2.90
- Analyst Target
- $15.00
- Dividend Yield
- N/A
- Beta
- 1.93
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
Company websiteResearch NTRB on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.